Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
406.71
458.22
421.71
437.33
423.13
399.07
407.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
406.71
458.22
421.71
437.33
423.13
399.07
407.77
Raw Material Cost
269.64
304.67
279.22
302.62
303.05
310.19
348.54
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
1.83
1.48
0.51
2.46
9.16
8.47
Selling and Distribution Expenses
37.64
35.70
41.92
34.67
25.38
28.44
20.86
Other Expenses
2.69
2.01
2.23
2.00
1.26
0.31
0.62
Total Expenditure (Excl Depreciation)
334.18
362.30
344.94
357.78
343.52
350.94
384.07
Operating Profit (PBDIT) excl Other Income
72.5
95.9
76.8
79.5
79.6
48.099999999999994
23.700000000000003
Other Income
65.40
8.22
6.86
6.37
10.46
6.33
6.11
Operating Profit (PBDIT)
164.56
129.46
111.22
113.14
116.26
80.82
55.83
Interest
0.00
1.83
1.48
0.51
2.46
9.16
8.47
Exceptional Items
13.24
-8.76
-5.17
-1.11
-1.22
8.71
13.81
Gross Profit (PBDT)
137.07
153.55
142.49
134.72
120.08
88.87
59.23
Depreciation
31.54
31.54
30.50
30.50
29.69
29.69
28.95
Profit Before Tax
146.26
87.34
74.07
81.01
82.89
50.68
32.23
Tax
18.06
9.10
9.06
10.07
10.13
5.90
4.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
128.09
77.67
65.25
70.72
72.68
44.50
27.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
128.09
77.67
65.25
70.72
72.68
44.50
27.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.11
0.57
-0.25
0.21
0.08
0.28
0.34
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
128.20
78.24
65.00
70.94
72.77
44.78
27.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,313.49
2,254.57
2,173.65
2,108.39
2,058.59
1,578.25
1,457.58
Earnings per share (EPS)
0.64
0.38
0.28
0.35
0.39
0.25
0.17
Diluted Earnings per share
0.64
0.38
0.28
0.35
0.39
0.25
0.17
Operating Profit Margin (Excl OI)
16.63%
19.58%
17.51%
17.44%
17.99%
11.23%
5.09%
Gross Profit Margin
43.72%
25.94%
24.8%
25.5%
26.61%
20.14%
15.0%
PAT Margin
31.49%
16.95%
15.47%
16.17%
17.18%
11.15%
6.74%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -11.24% vs 8.66% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 63.94% vs 20.31% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -18.15% vs 16.09% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -100.00% vs 20.00% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of HVSEN Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
406.71
0
406.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
406.71
0
406.71
Raw Material Cost
269.64
0
269.64
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
37.64
0
37.64
Other Expenses
2.69
0.00
2.69
Total Expenditure (Excl Depreciation)
334.18
0
334.18
Operating Profit (PBDIT) excl Other Income
72.53
0.00
72.53
Other Income
65.40
0
65.40
Operating Profit (PBDIT)
164.56
0
164.56
Interest
0.00
0
0.00
Exceptional Items
13.24
0
13.24
Gross Profit (PBDT)
137.07
0
137.07
Depreciation
31.54
0
31.54
Profit Before Tax
146.26
0
146.26
Tax
18.06
0
18.06
Provisions and contingencies
0
0
0.00
Profit After Tax
128.09
0
128.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
128.09
0
128.09
Share in Profit of Associates
0
0
0.00
Minority Interest
0.11
0
0.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
128.20
0
128.20
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,313.49
0
2,313.49
Earnings per share (EPS)
0.64
0
0.64
Diluted Earnings per share
0.64
0
0.64
Operating Profit Margin (Excl OI)
16.63%
0%
0.00
16.63%
Gross Profit Margin
43.72%
0%
0.00
43.72%
PAT Margin
31.49%
0%
0.00
31.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 40.67 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -11.24% vs 8.66% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.88% vs 84.36% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.82 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 63.94% vs 20.31% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 76.10% vs 305.07% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.92 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -18.15% vs 16.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -6.24% vs 453.93% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.63%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
